Obesity in Children (2015)

    Full Guidelines

    Click here to view article

    Tools

    Additional Documents

    Click here to see additional documents

    Endorsements

    College of Family Physicians of Canada

    This Clinical Practice Guideline has been endorsed by the College of Family Physicians of Canada.

    Summary of recommendations for clinicians and policy-makers

    The CTFPHC will continue to carefully monitor the scientific developments in the prevention and management of obesity and will report back to Canadians within 5 years with an update of the 2015 guidelines.

     

    Recommendations

    The growth monitoring recommendations apply to all children and youth 0–17 years of age who present to primary care.

    • We recommend growth monitoring at all appropriate1 primary care visits using the 2014 WHO Growth Charts for Canada.
      (Strong recommendation; very low quality evidence)The prevention recommendations apply to all children and youth 0–17 years of age who have a healthy weight. They do not apply to children and youth with eating disorders, or who are underweight, overweight, or obese.
    • We recommend that primary care practitioners not routinely offer structured interventions2 aimed at preventing overweight and obesity in healthy weight children and youth.
      (Weak recommendation; very low quality evidence)The management recommendations apply to children and youth 2–17 years of age who are overweight or obese. Children and youth with health conditions where weight management is inappropriate are excluded.

      • For children and youth aged 2 to 17 years who are overweight or obese, we recommend that primary care practitioners offer or refer to structured behavioural interventions3 aimed at healthy weight management.
        (Weak recommendation; moderate quality evidence)
      • For children and youth aged 2 to 11 years who are overweight or obese, we recommend that primary care practitioners not offer Orlistat aimed at healthy weight management.
        (Strong recommendation; very low quality evidence)
      • For children and youth aged 12 to 17 years who are overweight or obese, we recommend that primary care practitioners not routinely offer Orlistat aimed at healthy weight management.
        (Weak recommendation; moderate quality evidence)
      • For children and youth aged 2 to 17 years who are overweight or obese, we recommend that primary care practitioners not routinely refer for surgical interventions.
        (Strong recommendation; very low quality evidence)

     

    Continuing Medical Eduation

     

    Skip to toolbar